Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome
September 11, 2025
September 11, 2025
WASHINGTON, Sept. 11 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome
*
Milan, Italy: Children and teens diagnosed with Rett Syndrome (RTT) who take Epidiolex experience reductions in seizure frequency, according to data published in the Open Access Journal . . .
* * *
Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome
*
Milan, Italy: Children and teens diagnosed with Rett Syndrome (RTT) who take Epidiolex experience reductions in seizure frequency, according to data published in the Open Access Journal . . .